Analysis of medication prescribing errors in critically ill children

Corina Glanzmann1, Bernhard Frey2, Christoph R Meier3

  • 1Hospital Pharmacy, University Children's Hospital Zürich, Steinwiesstrasse 75, 8032, Zürich, Switzerland. pharma@kispi.uzh.ch.

Insights

Medication prescribing errors (MPEs) occurred in 14% of orders in a pediatric intensive care unit (PICU). Most errors required intervention or caused harm, highlighting the need for improved patient safety measures.

Area of Science:

  • Pediatric Intensive Care
  • Clinical Pharmacy
  • Patient Safety

Background:

  • Medication prescribing errors (MPEs) are a frequent type of medication error, with higher incidence in pediatric populations compared to adults.
  • Risk factors for MPEs include specific medication classes, prolonged PICU stays, and mechanical ventilation.
  • Analyzing the interplay between frequent prescribing errors and their severity is crucial for understanding patient risk.

Purpose of the Study:

  • To prospectively identify and quantify medication prescribing errors in critically ill children.
  • To determine the frequency, type, and severity of MPEs within a pediatric intensive care unit (PICU).
  • To provide data that can inform strategies for error reduction and improved patient safety.

Main Methods:

  • A prospective observational study was conducted in a PICU.
  • A clinical pharmacist prospectively identified medication prescribing errors.
  • A total of 1129 medication orders were analyzed.

Main Results:

  • An overall medication prescribing error rate of 14% was observed (151 errors out of 1129 orders).
  • Medication groups with the highest error rates included antihypertensives, antimycotics, and nasal preparation drugs (50% each).
  • 70% of MPEs (104 errors) required intervention or resulted in patient harm, representing 9% of all medication orders.

Conclusions:

  • The study identified a significant rate of medication prescribing errors in a PICU setting.
  • Specific medication classes were associated with a higher proportion of errors.
  • These findings can guide interventions to reduce MPEs and enhance patient safety in pediatric intensive care.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
391
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
101
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
886
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
838
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
505
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
360